Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2011 1
2012 5
2013 3
2014 1
2015 1
2016 8
2017 3
2018 3
2019 9
2020 16
2021 17
2022 11
2023 13
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

79 results

Results by year

Filters applied: . Clear all
Page 1
Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial.
Herrlinger U, Tzaridis T, Mack F, Steinbach JP, Schlegel U, Sabel M, Hau P, Kortmann RD, Krex D, Grauer O, Goldbrunner R, Schnell O, Bähr O, Uhl M, Seidel C, Tabatabai G, Kowalski T, Ringel F, Schmidt-Graf F, Suchorska B, Brehmer S, Weyerbrock A, Renovanz M, Bullinger L, Galldiks N, Vajkoczy P, Misch M, Vatter H, Stuplich M, Schäfer N, Kebir S, Weller J, Schaub C, Stummer W, Tonn JC, Simon M, Keil VC, Nelles M, Urbach H, Coenen M, Wick W, Weller M, Fimmers R, Schmid M, Hattingen E, Pietsch T, Coch C, Glas M; Neurooncology Working Group of the German Cancer Society. Herrlinger U, et al. Among authors: schafer n. Lancet. 2019 Feb 16;393(10172):678-688. doi: 10.1016/S0140-6736(18)31791-4. Epub 2019 Feb 14. Lancet. 2019. PMID: 30782343 Free article. Clinical Trial.
Primary CNS lymphoma: a clinician's guide.
Schäfer N, Glas M, Herrlinger U. Schäfer N, et al. Expert Rev Neurother. 2012 Oct;12(10):1197-206. doi: 10.1586/ern.12.120. Expert Rev Neurother. 2012. PMID: 23082736 Review.
Five-Fraction Stereotactic Radiotherapy for Brain Metastases-A Retrospective Analysis.
Layer JP, Layer K, Sarria GR, Röhner F, Dejonckheere CS, Friker LL, Zeyen T, Koch D, Scafa D, Leitzen C, Köksal M, Schmeel FC, Schäfer N, Landsberg J, Hölzel M, Herrlinger U, Schneider M, Giordano FA, Schmeel LC. Layer JP, et al. Among authors: schafer n. Curr Oncol. 2023 Jan 17;30(2):1300-1313. doi: 10.3390/curroncol30020101. Curr Oncol. 2023. PMID: 36826062 Free PMC article.
Distress in Neuro-Oncology Patients and Its Implications for Communication.
Roos C, Weller J, Landwehr C, Sciermoch A, Duffy C, Kohlmann K, Schaub C, Tzaridis T, Schneider M, Schuss P, Herrlinger U, Schäfer N. Roos C, et al. Among authors: schafer n. J Adv Pract Oncol. 2023 May;14(4):292-299. doi: 10.6004/jadpro.2023.14.4.3. Epub 2023 May 1. J Adv Pract Oncol. 2023. PMID: 37313277 Free PMC article.
Vemurafenib for leptomeningeal melanomatosis.
Schäfer N, Scheffler B, Stuplich M, Schaub C, Kebir S, Rehkämper C, Mack F, Niehusmann P, Simon M, Greschus S, Kuchelmeister K, Herrlinger U, Glas M. Schäfer N, et al. J Clin Oncol. 2013 Apr 10;31(11):e173-4. doi: 10.1200/JCO.2012.46.5773. Epub 2013 Mar 4. J Clin Oncol. 2013. PMID: 23460716 No abstract available.
A novel serum extracellular vesicle protein signature to monitor glioblastoma tumor progression.
Tzaridis T, Weller J, Bachurski D, Shakeri F, Schaub C, Hau P, Buness A, Schlegel U, Steinbach JP, Seidel C, Goldbrunner R, Schäfer N, Wechsler-Reya RJ, Hallek M, Scheffler B, Glas M, Haeberle L, Herrlinger U, Coch C, Reiners KS, Hartmann G. Tzaridis T, et al. Among authors: schafer n. Int J Cancer. 2023 Jan 15;152(2):308-319. doi: 10.1002/ijc.34261. Epub 2022 Sep 17. Int J Cancer. 2023. PMID: 36054558 Free article.
Outcome of Elderly Patients With Surgically Treated Brain Metastases.
Heimann M, Schäfer N, Bode C, Borger V, Eichhorn L, Giordano FA, Güresir E, Jacobs AH, Ko YD, Landsberg J, Lehmann F, Radbruch A, Schaub C, Schwab KS, Weller J, Herrlinger U, Vatter H, Schuss P, Schneider M. Heimann M, et al. Among authors: schafer n. Front Oncol. 2021 Jul 26;11:713965. doi: 10.3389/fonc.2021.713965. eCollection 2021. Front Oncol. 2021. PMID: 34381733 Free PMC article.
Regorafenib in advanced high-grade glioma: a retrospective bicentric analysis.
Tzaridis T, Gepfner-Tuma I, Hirsch S, Skardelly M, Bender B, Paulsen F, Schaub C, Weller J, Schäfer N, Herrlinger U, Tabatabai G. Tzaridis T, et al. Among authors: schafer n. Neuro Oncol. 2019 Jul 11;21(7):954-955. doi: 10.1093/neuonc/noz071. Neuro Oncol. 2019. PMID: 31089718 Free PMC article. No abstract available.
79 results